EDGAR Filing Documents for 0001144204-18-025776

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001144204-18-025776

Filing Date

2018-05-07

Accepted

2018-05-07 17:28:51

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	tv493141_s3.htm	S-3	483974
2	EXHIBIT 4.2	tv493141_ex4-2.htm	EX-4.2	270938
3	EXHIBIT 4.3	tv493141_ex4-3.htm	EX-4.3	268263
4	EXHIBIT 5.1(A)	tv493141_ex5-1a.htm	EX-5.1A	20802
5	EXHIBIT 5.1(B)	tv493141_ex5-1b.htm	EX-5.1B	28255
6	EXHIBIT 12.1	tv493141_ex12-1.htm	EX-12.1	23271
7	EXHIBIT 23.1	tv493141_ex23-1.htm	EX-23.1	3476
8	GRAPHIC	tv493141_img01.jpg	GRAPHIC	89258
9	GRAPHIC	tv493141_img02.jpg	GRAPHIC	90171
10	GRAPHIC	tv493141_logo01.jpg	GRAPHIC	8626
11	GRAPHIC	tv493141_ex5-1aimg01.jpg	GRAPHIC	6225
	Complete submission text file	0001144204-18-025776.txt		1368410

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850

Business Address 617 DETROIT STREET, SUITE 100 ANN ARBOR MI 48104 (734) 332-7800

Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)